Conformational variability of matrix metalloproteinases: beyond a single 3D structure.
暂无分享,去创建一个
Ivano Bertini | Claudio Luchinat | Paola Turano | Vito Calderone | Marco Fragai | I. Bertini | C. Luchinat | V. Calderone | S. Mangani | M. Fragai | P. Turano | Yong‐Min Lee | Stefano Mangani | Beatrice Terni | Marta Cosenza | Yong-Min Lee | B. Terni | M. Cosenza
[1] I. Bertini,et al. Crystal structure of the catalytic domain of human matrix metalloproteinase 10. , 2004, Journal of molecular biology.
[2] N. Borkakoti. Matrix metalloprotease inhibitors: design from structure. , 2004, Biochemical Society transactions.
[3] I. Bertini,et al. X-ray structures of binary and ternary enzyme-product-inhibitor complexes of matrix metalloproteinases. , 2003, Angewandte Chemie.
[4] L Steinman,et al. Multiple Sclerosis: A Coordinated Immunological Attack against Myelin in the Central Nervous System , 1996, Cell.
[5] B. Fingleton,et al. Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.
[6] R. Powers,et al. High-resolution solution structure of the inhibitor-free catalytic fragment of human fibroblast collagenase determined by multidimensional NMR. , 1998, Biochemistry.
[7] N. Borkakoti. Structural studies of matrix metalloproteinases , 2000, Journal of Molecular Medicine.
[8] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[9] J. Reynolds,et al. The origin of matrix metalloproteinases and their familial relationships , 1991, FEBS letters.
[10] Y. Li,et al. Solution structure of the catalytic domain of human stromelysin-1 complexed to a potent, nonpeptidic inhibitor. , 1998, Biochemistry.
[11] L. Kay,et al. Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease. , 1989, Biochemistry.
[12] M. Billeter,et al. MOLMOL: a program for display and analysis of macromolecular structures. , 1996, Journal of molecular graphics.
[13] A. Gearing,et al. Design and therapeutic application of matrix metalloproteinase inhibitors. , 1999, Chemical reviews.
[14] L. Kay,et al. Pulse sequences for removal of the effects of cross correlation between dipolar and chemical-shift anisotropy relaxation mechanisms on the measurement of heteronuclear T1 and T2 values in proteins , 1992 .
[15] C. Cambillau,et al. Dynamics of Fusarium solani cutinase investigated through structural comparison among different crystal forms of its variants , 1996, Proteins.
[16] R. Powers,et al. Impact of mobility on structure-based drug design for the MMPs. , 2002, Journal of the American Chemical Society.
[17] Maria Pavlaki,et al. Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trials , 2003, Cancer and Metastasis Reviews.
[18] W. Stallings,et al. Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor. , 2002, Biochimica et biophysica acta.
[19] X. Zhang,et al. Solution structure of the catalytic domain of human collagenase-3 (MMP-13) complexed to a potent non-peptidic sulfonamide inhibitor: binding comparison with stromelysin-1 and collagenase-1. , 2000, Journal of molecular biology.
[20] W. Stetler-Stevenson,et al. Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. , 1996, Seminars in cancer biology.
[21] R. Powers,et al. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor. , 2000, Journal of molecular biology.
[22] P. Wright,et al. Suppression of the effects of cross-correlation between dipolar and anisotropic chemical shift relaxation mechanisms in the measurement of spin-spin relaxation rates , 1992 .
[23] H. Birkedal‐Hansen. Proteolytic remodeling of extracellular matrix. , 1995, Current opinion in cell biology.
[24] M Ikura,et al. Backbone dynamics of calmodulin studied by 15N relaxation using inverse detected two-dimensional NMR spectroscopy: the central helix is flexible. , 1992, Biochemistry.
[25] D. Hupe,et al. Solution structure of the catalytic domain of human stromelysin complexed with a hydrophobic inhibitor , 1995, Protein science : a publication of the Protein Society.
[26] K. Wüthrich,et al. Torsion angle dynamics for NMR structure calculation with the new program DYANA. , 1997, Journal of molecular biology.
[27] R. Huber,et al. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure. , 2001, Journal of molecular biology.
[28] J. Thornton,et al. AQUA and PROCHECK-NMR: Programs for checking the quality of protein structures solved by NMR , 1996, Journal of biomolecular NMR.
[29] J. Prestegard,et al. Residual dipolar couplings in structure determination of biomolecules. , 2004, Chemical reviews.
[30] Soumyendu Raha,et al. Similarity of Binding Sites of Human Matrix Metalloproteinases*[boxs] , 2004, Journal of Biological Chemistry.